Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Cancer

• Publication date

  1997-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0959-8049(96)00426-1PMID 9135505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data

  2004cited by this paper
• Pharmacokinetics of vinorelbine in man

  2004cited by this paper
• Pharmacokinetics of vinorelbine in patients with liver metastases

  1996cited by this paper
• Sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of vinorelbine plasma concentrations.

  1996cited by this paper
• Entry and evaluation of elderly patients in european organization for research and treatment of cancer (EORTC) new‐drug–development studies

  1995cited by this paper
• Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.

  1994cited by this paper
• Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

  1994cited by this paper
• Cancer pharmacology in the elderly.

  1993cited by this paper
• Cancer statistics, 1993

  1993cited by this paper
• Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

  1993cited by this paper
• Pharmacology and organ toxicity of chemotherapy in older patients.

  1992cited by this paper
• Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.

  1991cited by this paper
• Management of drug therapy in the elderly.

  1989cited by this paper
• Pharmacokinetics and metabolism of Navelbine.

  1989cited by this paper

• Novel red carbon dots-based fluorescence sensor for sensitive detection of vinorelbine: pharmacokinetic evaluation in breast and lung cancer patients

  2025cites this paper
• Chemotherapy dosing in older adults with cancer: One size does NOT fit all.

  2022cites this paper
• An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

  2022cites this paper
• Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low‐grade glioma

  2021cites this paper
• Systemic Treatment of Metastatic Breast Cancer in Older Adults

  2020cites this paper
• Medical Management of Advanced Disease

  2019cites this paper
• Principles of Chemotherapy in Older Adults

  2019cites this paper
• Fatal iatrogenic vinorelbine poisoning: a case report.

  2019cites this paper
• Triple-Negative Breast Cancer

  2018cites this paper
• Individualizing the Approach to the Older Woman with Triple-Negative Breast Cancer

  2018cites this paper
• Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults

  2017cites this paper
• Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

  2016cites this paper
• Optimal management of breast cancer in the elderly patient: current perspectives

  2015cites this paper
• Effect of age on drug metabolism in women with breast cancer

  2015cites this paper
• Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient.

  2014cites this paper
• An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment

  2013influential citation
• Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Lung Cancer Treatment

  2013cites this paper
• Pharmacology of aging and cancer: how useful are pharmacokinetic tests?.

  2013cites this paper
• Chapter 9 – Chemotherapy

  2012cites this paper
• [Breast cancer in older women].

  2012cites this paper
• Therapeutic management of breast cancer in the elderly

  2011cites this paper
• Chemotherapy treatment for older women with metastatic breast cancer: what is the evidence?

  2011cites this paper
• Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults

  2011cites this paper
• Impact of age, sex, and comorbidity on cancer therapy and disease progression.

  2010cites this paper
• Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer.

  2010cites this paper
• Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Breast Cancer Treatment

  2010cites this paper
• Vinorelbine for non-small cell lung cancer

  2010cites this paper
• A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

  2009cites this paper
• Chemotherapy for the Older Adult with Cancer

  2009cites this paper
• A Review of Vinorelbine in the Treatment of Advanced Breast Cancer

  2009cites this paper
• Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.

  2008cites this paper
• Chemotherapy and targeted agents for elderly women with advanced breast cancer.

  2008cites this paper
• Treatment of advanced breast cancer in elderly women: medical approach

  2008cites this paper
• Clinical pharmacology of cancer therapies in older adults

  2008cites this paper
• Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer

  2008cites this paper
• Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study

  2008cites this paper
• Pharmacokinetics of chemotherapy in the older patient.

  2007cites this paper
• International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.

  2007cites this paper
• Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy.

  2007cites this paper
• Cancer du sein chez les femmes âgées

  2007cites this paper
• Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study.

  2006cites this paper
• Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy.

  2006cites this paper
• The absolute bioavailability of oral vinorelbine in patients with solid tumors

  2005cites this paper
• Chemotherapy of breast cancer in the elderly.

  2005cites this paper
• Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.

  2005cites this paper
• Breast cancer in older patients.

  2004cites this paper
• Pharmacokinetics in older persons.

  2004cites this paper
• Chemotherapy in the elderly.

  2004cites this paper
• Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics.

  2004cites this paper
• Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer

  2004cites this paper
• Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences

  2004cites this paper
• Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

  2004cites this paper
• Non-Small-Cell Lung Cancer in Elderly Patients: Influence of Age on Vinorelbine Oral Pharmacokinetics original contribution

  2004cites this paper
• Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly.

  2003cites this paper
• Pharmacology of Anticancer Drugs in the Elderly Population

  2003cites this paper
• Pharmacological Factors Influencing Anticancer Drug Selection in the Elderly

  2003cites this paper
• Vinorelbine and Prednisone in older Cancer Patients with Hormone-Refractory Metastatic Prostate Cancer a Phase II Study

  2003cites this paper
• Greater risks of chemotherapy toxicity in elderly patients with cancer.

  2003cites this paper
• Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.

  2003cites this paper
• Pharmacology of antineoplastic agents in older cancer patients.

  2003cites this paper
• Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

  2003cites this paper
• Internistisch-onkologische Therapie

  2002cites this paper
• Breast Cancer: Single Agents Chemotherapy

  2002cites this paper
• A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer

  2002cites this paper
• Prescribing anti-cancer drugs in elderly cancer patients.

  2002cites this paper
• Pharmacokinetics of Navelbine® Oral in Elderly Patients

  2002cites this paper
• Vinorelbine

  2002cites this paper
• Strategies for Improving Quality of Life in Older Patients with Metastatic Breast Cancer

  2002cites this paper
• Critical Review of Current Treatment Strategies for Advanced Hormone Insensitive Breast Cancer

  2002cites this paper
• The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer

  2002cites this paper
• Systemic therapy for older women with breast cancer.

  2001cites this paper
• Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer

  2001cites this paper
• Medical oncology.

  2001cites this paper
• Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine.

  2001cites this paper
• Chemotherapy in the elderly: pharmacologic considerations.

  2000cites this paper
• BREAST CANCER AND AGING: Clinical Interactions

  2000cites this paper
• Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.

  2000cites this paper
• Pharmacology of antineoplastic agents in older cancer patients.

  2000cites this paper
• Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older.

  1999cites this paper
• Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer.

  1999cites this paper
• Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells.

  1999cites this paper
• Cost-Utility A nalysis o f C hemotherapy U sing P aclitaxel, Docetaxel, o r V inorelbine f or P atients W ith Anthracycline-Resistant B reast C ancer

  1999cites this paper
• Practical Treatment Guide for Dose Individualisation in Cancer Chemotherapy

  1998cites this paper
• Quality of life issues in the treatment of metastatic breast cancer.

  1998cites this paper